The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial

Article

Abstract: Background: Cardiovascular outcome trials have suggested that glucagon-like peptide 1 (GLP-1) recept

Palabras claves:

Autores:

Atisso C.M., Avezum A.J., Basile J.N., Botros F.T., Colhoun H.M., Conget I., Cushman W.C., DIaz R., Dyal L., Gerstein H.C., Hall S., Hâncu N., Hanefeld M., Hart R.G., Jansky P., Keltai M., Lakshmanan M., Lanas F.T., Leiter L.A., Munoz E.G.C., PATRICIO LOPEZ -JARAMILLO, Pogosova N., Probstfield J.L., Raubenheimer P.J., Riddle M.C., Rydén L.E., Shaw J.E., Sheu W.H.H., Temelkova-Kurktschiev T.

Fuentes:

google

scopus